EJMK Ventures’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EJMK Ventures's AZN Position: Q3 2026 in Review
EJMK Ventures reduced its AstraZeneca (AZN) stake by 13% in Q3 2026, selling an estimated $45.8K and leaving 1,892 shares worth $306K. The position accounts for 0.13% of the portfolio, ranked #124.
EJMK Ventures first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $850K in Q4 2025. 1,444 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- EJMK Ventures held 1,892 shares of AstraZeneca worth $306K as of Q3 2026.
- EJMK Ventures sold 275 AstraZeneca shares in Q3 2026, an estimated $45.8K.
- AstraZeneca made up 0.13% of EJMK Ventures's portfolio in Q3 2026, its #124 holding.
- EJMK Ventures first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
- EJMK Ventures's AstraZeneca position peaked at $850K in Q4 2025.
- 1,444 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.